Smith & Nephew Guidance Cut Was Expected, J.P. Morgan Says

J.P. Morgan analysts say Smith & Nephew's reduced guidance was expected and its results were slightly better than feared. They also say the company's exploration of strategic options for its orthopedics business is likely to be welcomed.